These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31557622)

  • 1. Umbelliferone derivatives exert neuroprotective effects by inhibiting monoamine oxidase A, self-amyloidβ aggregation, and lipid peroxidation.
    Seong SH; Ali MY; Jung HA; Choi JS
    Bioorg Chem; 2019 Nov; 92():103293. PubMed ID: 31557622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Umbelliferone Based Derivatives as Potent MAO Inhibitors: Dry vs. Wet Lab Evaluation.
    Dhiman P; Malik N; Khatkar A
    Curr Top Med Chem; 2018; 18(21):1857-1871. PubMed ID: 30430943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
    Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
    Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
    Baek SC; Kang MG; Park JE; Lee JP; Lee H; Ryu HW; Park CM; Park D; Cho ML; Oh SR; Kim H
    Bioorg Med Chem Lett; 2019 Mar; 29(6):839-843. PubMed ID: 30686752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
    Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
    Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies.
    Elkamhawy A; Paik S; Park JH; Kim HJ; Hassan AHE; Lee K; Park KD; Roh EJ
    Bioorg Chem; 2021 Oct; 115():105233. PubMed ID: 34390968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the inhibitory effects of eckol and dieckol isolated from edible brown alga Eisenia bicyclis on human monoamine oxidases A and B.
    Jung HA; Roy A; Jung JH; Choi JS
    Arch Pharm Res; 2017 Apr; 40(4):480-491. PubMed ID: 28251489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives.
    Oh JM; Kang MG; Hong A; Park JE; Kim SH; Lee JP; Baek SC; Park D; Nam SJ; Cho ML; Kim H
    Int J Biol Macromol; 2019 Sep; 137():426-432. PubMed ID: 31271801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
    Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
    Zarmouh NO; Eyunni SK; Soliman KF
    BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
    Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
    Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease.
    Yang HL; Cai P; Liu QH; Yang XL; Fang SQ; Tang YW; Wang C; Wang XB; Kong LY
    Bioorg Med Chem; 2017 Nov; 25(21):5917-5928. PubMed ID: 28988627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease.
    Reeta ; Baek SC; Lee JP; Rangarajan TM; Ayushee ; Singh RP; Singh M; Mangiatordi GF; Nicolotti O; Kim H; Mathew B
    CNS Neurol Disord Drug Targets; 2019; 18(8):643-654. PubMed ID: 31550216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition.
    El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
    Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.
    Wang D; Hong RY; Guo M; Liu Y; Chen N; Li X; Kong DX
    Molecules; 2019 Nov; 24(21):. PubMed ID: 31694262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.
    Chavarria D; Fernandes C; Silva V; Silva C; Gil-Martins E; Soares P; Silva T; Silva R; Remião F; Oliveira PJ; Borges F
    Eur J Med Chem; 2020 Jan; 185():111770. PubMed ID: 31711793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
    Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and Molecular Docking Studies of 6-Formyl Umbelliferone Isolated from Angelica decursiva as an Inhibitor of Cholinesterase and BACE1.
    Ali MY; Seong SH; Reddy MR; Seo SY; Choi JS; Jung HA
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28946641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
    Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
    Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase A and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives.
    Bekircan O; Danış Ö; Şahin ME; Çetin M
    Bioorg Chem; 2022 Jan; 118():105493. PubMed ID: 34814086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.